Neogenomics, Inc. (NGNM) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	28.94M
Restricted cash
Accounts receivable (net of allowance for doubtful accounts of $1,843 and $1,459, respectively)	50.18M
Inventories	5.95M
Other current assets	7.49M
Total current assets	92.56M
PROPERTY AND EQUIPMENT (net of accumulated depreciation of $5,530 and $4,568 respectively)	34.17M
DEPOSITS
TOTAL ASSETS	355.43M
Accounts payable	13.98M
Accrued compensation	11.38M
Other accrued expenses and liabilities
Short-term portion of equipment capital leases	5M
Revolving credit line
Total current liabilities	35.39M
Long-term portion of equipment capital leases	5.51M
TOTAL LIABILITIES	109.34M
Common stock, $.001 par value, (100,000,000 shares authorized; 42,890,203 and 37,341,285 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively)
Additional paid-in capital	238.98M
Accumulated deficit	-38.26M
Total stockholders' equity	200.79M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	355.43M

Entities mentioned with NGNM

View All Entities